1991
DOI: 10.1007/bf00685518
|View full text |Cite
|
Sign up to set email alerts
|

Single-dose i.v. dexamethasone?an effective anti-emetic in cancer chemotherapy

Abstract: We conducted a randomised, single-blind, placebo-controlled crossover study to assess the efficacy of a single i.v. dose of 20 mg dexamethasone as an anti-emetic in 31 patients receiving cancer chemotherapy. Patients receiving dexamethasone experienced significantly less nausea and vomiting (P less than 0.001 and P less than 0.01, respectively), and appetite and activity were normal in a majority of the treated group. Side effects were insignificant. We conclude that single-dose dexamethasone given i.v. at a d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
5
0

Year Published

1992
1992
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…In recent years there has been considerable interest in dexamethasone for reducing postoperative nausea and vomiting. Although the mechanism of its antiemetic effect is not known, dexamethasone has been used as an antiemetic drug during chemotherapy in oncology patients [2][3][4] . Dexamethasone has a long duration of action with a biological half-life up to 72 hours 5 .…”
mentioning
confidence: 99%
“…In recent years there has been considerable interest in dexamethasone for reducing postoperative nausea and vomiting. Although the mechanism of its antiemetic effect is not known, dexamethasone has been used as an antiemetic drug during chemotherapy in oncology patients [2][3][4] . Dexamethasone has a long duration of action with a biological half-life up to 72 hours 5 .…”
mentioning
confidence: 99%
“…Expression of this protein is found in T lymphocytes, macrophages, platelets, synovial fibroblasts, tubule epithelial cells, and tumor cells ( 17 ). According to recent studies, CCL5 promotes tumor progression by enhancing tumor metastasis ( 18 ) and remodeling the extracellular matrix, which results in supporting tumor stem cell expansion ( 19 ), causing tumor cells drug-resistant ( 20 ), reducing the cytotoxicity of DNA damage factors, decompressing cellular metabolic reprogramming ( 21 ), increasing angiogenesis, mobilizing immune cells ( 22 ), and inducing macrophage polarization to suppress immune response ( 23 ). However, the underlying mechanism of CCL5 in BC remains unclear.…”
Section: Introductionmentioning
confidence: 99%
“…Arising from the speculation that severe nausea and vomiting of pregnancy may result from adrenocorticotropic hormone deficiency (2) and from the successful use of steroids for chemotherapyinduced emesis (3,4), studies have been conducted on various steroid therapy regimes in hyperemesis demonstrating significant benefits of steroids in respect to well-being, food intake, and weight gain (1,2,5).…”
mentioning
confidence: 99%